USE OF BOTULINUM NEUROPROTEIN TYPE A IN TREATMENT OF FOCAL MUSCULAR DYSTONIAS

Abstract

Dystonia ranks the 2-3rd among all forms of motor disorders. The most frequent are two forms of dystonia: blepharospasm and cervical dystonia (spastic dystonia). The main task in the treatment of dystonia is to achieve a stable remission of the disease while maintaining the patient's ability to work and social activity and preventing the recurrence of symptoms. The clinical effect after the injection of botulinum toxin type A (BTA) is manifested in the form of a marked decrease in muscle tension, spasms and pain.We analyzed the results of management of 43 in-patients with focal muscular dystonias using botulinum toxins in the University Hospital of Bashkir State Medical University in Ufa. Evaluation of the dystonia and effectiveness of the treatment was carried out using the scales of spasmodic torticollis of the Western Toronto TWSTRS, photo and video recording. The reduction of dystonicpostures and pain was observed in most of the cases. We underline the positive features and the things to be improved for optimiz-ing the efficiency and quality control of medical rehabilitation in focal muscular dystonias.